99 related articles for article (PubMed ID: 11900409)
1. Contributions of mouse biology to breast cancer research.
Cardiff RD; Bern HA; Faulkin LJ; Daniel CW; Smith GH; Young LJ; Medina D; Gardner MB; Wellings SR; Shyamala G; Guzman RC; Rajkumar L; Yang J; Thordarson G; Nandi S; MacLeod CL; Oshima RG; Man AK; Sawai ET; Gregg JP; Cheung AT; Lau DH
Comp Med; 2002 Feb; 52(1):12-31. PubMed ID: 11900409
[No Abstract] [Full Text] [Related]
2. Mouse models for breast cancer.
Hennighausen L
Oncogene; 2000 Feb; 19(8):966-7. PubMed ID: 10713679
[No Abstract] [Full Text] [Related]
3. Validity of mouse mammary tumour models for human breast cancer: comparative pathology.
Cardiff RD
Microsc Res Tech; 2001 Jan; 52(2):224-30. PubMed ID: 11169869
[TBL] [Abstract][Full Text] [Related]
4. UCLA colloquium. New insights into breast cancer: the molecular biochemical and cellular biology of breast cancer.
Dickson RB; Lippman ME; Slamon D
Cancer Res; 1990 Jul; 50(14):4446-7. PubMed ID: 2163750
[No Abstract] [Full Text] [Related]
5. YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification.
Bergmann S; Royer-Pokora B; Fietze E; Jürchott K; Hildebrandt B; Trost D; Leenders F; Claude JC; Theuring F; Bargou R; Dietel M; Royer HD
Cancer Res; 2005 May; 65(10):4078-87. PubMed ID: 15899797
[TBL] [Abstract][Full Text] [Related]
6. Location, location, location: regulation of breast cancer progression by the microenvironment.
Lee AV
Breast Cancer Res; 2004; 6(6):279-80. PubMed ID: 15535860
[No Abstract] [Full Text] [Related]
7. [Establishment of a whole-body visualization model of breast cancer with high hepatic metastatic potential in nude mice through serial passage in vivo].
Yang M; Yang ZH; Hou ZD; Li XN
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):944-7. PubMed ID: 18583234
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.
Lin SC; Lee KF; Nikitin AY; Hilsenbeck SG; Cardiff RD; Li A; Kang KW; Frank SA; Lee WH; Lee EY
Cancer Res; 2004 May; 64(10):3525-32. PubMed ID: 15150107
[TBL] [Abstract][Full Text] [Related]
9. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
Jacquemart IC; Springs AE; Chen WY
Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488
[TBL] [Abstract][Full Text] [Related]
10. [The most recent biochemical studies in experimental animal models of breast neoplasms].
Corongiu F; Rosso P
Ann Osp Maria Vittoria Torino; 1974; 17(1-6):166-84. PubMed ID: 4377391
[No Abstract] [Full Text] [Related]
11. Cell kinetics of human breast cancer and relationship to animal models.
Schiffer LM
Bull Cancer; 1978; 65(4):455-6. PubMed ID: 747802
[No Abstract] [Full Text] [Related]
12. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
13. The genetic pathology of breast cancer.
Callahan R; Cropp C; Gallahan D; Liscia D; Merlo G; Smith GH; Lidereau R
Prog Clin Biol Res; 1992; 376():117-36. PubMed ID: 1528917
[No Abstract] [Full Text] [Related]
14. Mouse models of human breast cancer.
Cardiff RD
Comp Med; 2003 Jun; 53(3):250-3. PubMed ID: 12868567
[No Abstract] [Full Text] [Related]
15. The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans.
Moynahan ME
Oncogene; 2002 Dec; 21(58):8994-9007. PubMed ID: 12483515
[TBL] [Abstract][Full Text] [Related]
16. Micromanaging metastasis.
Schuldt A
Nat Cell Biol; 2007 Oct; 9(10):1121. PubMed ID: 17909523
[No Abstract] [Full Text] [Related]
17. Clinically relevant metastatic breast cancer models to study chemosensitivity.
Kim LS; Price JE
Methods Mol Med; 2005; 111():285-95. PubMed ID: 15911986
[TBL] [Abstract][Full Text] [Related]
18. Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesis.
Mollenhauer J; Helmke B; Medina D; Bergmann G; Gassler N; Müller H; Lyer S; Diedrichs L; Renner M; Wittig R; Blaich S; Hamann U; Madsen J; Holmskov U; Bikker F; Ligtenberg A; Carlén A; Olsson J; Otto HF; O'Malley B; Poustka A
Genes Chromosomes Cancer; 2004 Mar; 39(3):185-94. PubMed ID: 14732920
[TBL] [Abstract][Full Text] [Related]
19. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
Ursini-Siegel J; Rajput AB; Lu H; Sanguin-Gendreau V; Zuo D; Papavasiliou V; Lavoie C; Turpin J; Cianflone K; Huntsman DG; Muller WJ
Mol Cell Biol; 2007 Sep; 27(18):6361-71. PubMed ID: 17636013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
